share_log

Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Opaleye Management Inc.(5.14%)

SEC announcement ·  Jan 5 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more